Michael A. Rossi - Jul 18, 2021 Form 4 Insider Report for HARVARD BIOSCIENCE INC (HBIO)

Role: Chief Financial Officer
Signature: /s/ Michael A. Rossi
Stock symbol: HBIO
Transactions as of: Jul 18, 2021
Transactions value $: -$52,733
Form type: 4
Date filed: 7/20/2021, 04:01 PM
Previous filing: Jun 15, 2021
Next filing: Jan 3, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HBIO	Common Stock	Tax liability	-$52.7K	-6.97K	-2.93%	$7.57	231K	Jul 18, 2021	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with a performance restricted stock unit award previously granted to the Reporting Person that vested in part on July 18, 2021.
F2	Includes (a) 43,092 remaining restricted stock units that will vest on June 11, 2022 and 2023, (b) 38,462 restricted stock units that will vest in three equal installments on December 31, 2021, 2022 and 2023, (c) 36,876 restricted stock units with performance based vesting conditions, (d) 23,878 remaining restricted stock units that will vest on July 18, 2022, (e) 32,319 remaining restricted stock units that will vest on December 31, 2021, 2022 and 2023, and (f) 56,395 shares of common stock beneficially owned by the Reporting Person.

Content

The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with a performance restricted stock unit award previously granted to the Reporting Person that vested in part on July 18, 2021.

Includes (a) 43,092 remaining restricted stock units that will vest on June 11, 2022 and 2023, (b) 38,462 restricted stock units that will vest in three equal installments on December 31, 2021, 2022 and 2023, (c) 36,876 restricted stock units with performance based vesting conditions, (d) 23,878 remaining restricted stock units that will vest on July 18, 2022, (e) 32,319 remaining restricted stock units that will vest on December 31, 2021, 2022 and 2023, and (f) 56,395 shares of common stock beneficially owned by the Reporting Person.